FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Need for Device Transparency Seen in Celect Case

Academic medical center authors writing in the Annals of Internal Medicine say litigation involving the Cook Celect IVC filter demonstrates the need f...

latest-news-card-1
Medical Devices

PCCP Draft Guidance Stakeholder Recommendations

Two stakeholders request changes to an FDA draft guidance on predetermined change control plans for medical devices.

latest-news-card-1
Federal Register

FDA Revokes EUAs on Covid Tests

Federal Register notice: FDA revokes the Emergency Use Authorizations issued to Cue Health for the Cue Covid19 Test, and Cue Covid19 Home/OTC Test.

latest-news-card-1
Federal Register

FDA Provides More Draft ANDA-Specific Guidances

Federal Register notice: FDA makes available additional draft and revised draft product-specific guidances for generic drug sponsors.

latest-news-card-1
Human Drugs

Fludarabine Phosphate Labeling Changes OKd

FDA announces approved labeling changes for Sandoz fludarabine phosphate injection under the Oncology Center of Excellences Project Renewal.

latest-news-card-1
Medical Devices

FDA Clears Ultromics EchoGo Amyloidosis Device

FDA clears an Ultromics 510(k) for the EchoGo Amyloidosis for detecting cardiac amyloidosis.

latest-news-card-1
Human Drugs

Sage Ending Dalzanemdor Development

Sage says it is ending dalzanemdor development in Huntingtons disease cognitive impairment following Phase 2 DIMENSION results that did not meet prima...

latest-news-card-1
Medical Devices

Draeger Atlan Recall is Class 1

FDA says the Draeger recall correction of its Atlan A350 and A350XL anesthesia workstations is Class 1.

latest-news-card-1
Medical Devices

Smiths Recalls Infusion Pump Battery Packs

Smiths Medical recalls (Class 1) its CADD-Solis Li-ion Rechargeable Battery Packs to update instructions for use due to a potential battery malfunctio...

latest-news-card-1
Federal Register

Fortesta Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that Endos Fortesta (testosterone) gel was not withdrawn due to safety or effectiveness reasons.